Donna R. Cryer

7.3k total citations
17 papers, 483 citations indexed

About

Donna R. Cryer is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Donna R. Cryer has authored 17 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 7 papers in Hepatology and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Donna R. Cryer's work include Liver Disease Diagnosis and Treatment (11 papers), Liver Diseases and Immunity (5 papers) and Liver Disease and Transplantation (4 papers). Donna R. Cryer is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Liver Diseases and Immunity (5 papers) and Liver Disease and Transplantation (4 papers). Donna R. Cryer collaborates with scholars based in United States, United Kingdom and Switzerland. Donna R. Cryer's co-authors include Jessica Hwang, Andrew Artz, Mark R. Somerfield, Jordan J. Feld, Anita L. Sabichi, Barnett S. Kramer, Sandra L. Wong, Arun J. Sanyal, Mazen Noureddin and George L. Askew and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Journal of Hepatology.

In The Last Decade

Donna R. Cryer

17 papers receiving 474 citations

Peers

Donna R. Cryer
Faisal Abaalkhail Saudi Arabia
Sarah May United States
Chiara Mazzarelli Italy
José Ignacio Fortea Spain
Sylvia Dražilová Slovakia
N. S. Weiss United States
Edward W. Holt United States
Karen F. Murray United States
Seyed Ali Montazeri United States
Lanla Conteh United States
Faisal Abaalkhail Saudi Arabia
Donna R. Cryer
Citations per year, relative to Donna R. Cryer Donna R. Cryer (= 1×) peers Faisal Abaalkhail

Countries citing papers authored by Donna R. Cryer

Since Specialization
Citations

This map shows the geographic impact of Donna R. Cryer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna R. Cryer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna R. Cryer more than expected).

Fields of papers citing papers by Donna R. Cryer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna R. Cryer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna R. Cryer. The network helps show where Donna R. Cryer may publish in the future.

Co-authorship network of co-authors of Donna R. Cryer

This figure shows the co-authorship network connecting the top 25 collaborators of Donna R. Cryer. A scholar is included among the top collaborators of Donna R. Cryer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna R. Cryer. Donna R. Cryer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Boeckmans, Joost, Hannes Hagström, Donna R. Cryer, & Jörn M. Schattenberg. (2025). The importance of patient engagement in the multimodal treatment of MASLD. Communications Medicine. 5(1). 148–148. 3 indexed citations
2.
Nadolsky, Karl, et al.. (2023). Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey. Annals of Medicine. 55(1). 2211349–2211349. 5 indexed citations
3.
Eskridge, Wayne, Donna R. Cryer, Jörn M. Schattenberg, et al.. (2023). Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective. Journal of Clinical Medicine. 12(19). 6216–6216. 57 indexed citations
4.
Clark, Jeanne M., et al.. (2023). Nonalcoholic fatty liver disease from a primary care perspective. Diabetes Obesity and Metabolism. 25(6). 1421–1433. 12 indexed citations
5.
Twiss, James, Diane Whalley, Lynda Doward, et al.. (2023). Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis. Journal of Patient-Reported Outcomes. 7(1). 69–69. 5 indexed citations
6.
7.
Thomaides‐Brears, Helena, Naim Alkhouri, Daniela Allende, et al.. (2021). Incidence of Complications from Percutaneous Biopsy in Chronic Liver Disease: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences. 67(7). 3366–3394. 71 indexed citations
8.
Doward, Lynda, Maria‐Magdalena Balp, James Twiss, et al.. (2020). Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study. Patient. 14(5). 533–543. 45 indexed citations
9.
Hwang, Jessica, Jordan J. Feld, Sarah P. Hammond, et al.. (2020). Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. Journal of Clinical Oncology. 38(31). 3698–3715. 96 indexed citations
10.
Cryer, Donna R.. (2019). NASH and liver cancer: the new cancer headline.. PubMed. 25(11 Spec No.). SP334–SP335. 1 indexed citations
11.
Doward, Lynda, Maria‐Magdalena Balp, Christina Slota, et al.. (2018). Measuring what matters to patients: the development of the NASH-CHECK, a new patient-reported outcome instrument for nonalcoholic steatohepatitis. Journal of Hepatology. 68. S570–S570. 2 indexed citations
12.
Doward, Lynda, Maria‐Magdalena Balp, James Twiss, et al.. (2017). Understanding the patient-perceived impact of nonalcoholic steatohepatitis: Raising the volume on a silent disease. Hepatology. 66. 1 indexed citations
13.
Twiss, James, Maria‐Magdalena Balp, Lynda Doward, et al.. (2017). Development of a New Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis: Nash-Check. Value in Health. 20(9). A638–A638. 3 indexed citations
14.
Doward, Lynda, Maria‐Magdalena Balp, Donna R. Cryer, et al.. (2017). Exploring the patient perceived impact of non-alcoholic steatohepatitis. Journal of Hepatology. 66(1). S422–S423. 2 indexed citations
15.
Hwang, Jessica, Mark R. Somerfield, Donna R. Cryer, et al.. (2015). Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update. Journal of Clinical Oncology. 33(19). 2212–2220. 133 indexed citations
16.
Askew, George L., et al.. (1990). Informed consent: can we educate patients?. PubMed. 35(5). 308–10. 36 indexed citations
17.
Cryer, Donna R.. (1976). Bovine infectious keratoconjunctivitis. Veterinary Record. 98(2). 37–37. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Faisal Abaalkhail Breakdown of academic impact, for papers by Sarah May Breakdown of academic impact, for papers by Chiara Mazzarelli Breakdown of academic impact, for papers by José Ignacio Fortea Breakdown of academic impact, for papers by Sylvia Dražilová Breakdown of academic impact, for papers by N. S. Weiss Breakdown of academic impact, for papers by Edward W. Holt Breakdown of academic impact, for papers by Karen F. Murray Breakdown of academic impact, for papers by Seyed Ali Montazeri Breakdown of academic impact, for papers by Lanla Conteh
Rankless by CCL
2026